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A B S T R A C T
Charles Bonnet syndrome (CBS) is a condition related to patients with visual loss due to age related macular degen-
eration or glaucoma that are having complex visual hallucinations. The CBS was first described by Swiss physician
Charles Bonnet in 1760. Affected patients, who are otherwise mentally healthy people with significant visual loss, have
vivid, complex recurrent visual hallucinations (VHs). One characteristic of these hallucinations is that they usually are
»Lilliputian hallucinations« as patients experience micropsia (hallucinations in which the characters or objects are dis-
torted and much smaller than normal). The prevalence of Charles Bonnet Syndrome has been reported to be between 10%
and 40%; a recent Australian study has found the prevalence to be 17.5%. The high incidence of non-reported CBS is
thought to be as a result of patient’s fear to report the symptoms as they could be labeled as mentally insane since those
type of visual hallucinations could be found in variety of psychiatric and neurological disorders such as drug or alcohol
abuse (delirium tremens), Alice in Wonderland syndrome (AIWS), psychosis, schizophrenia, dementia, narcolepsy, epi-
lepsy, Parkinson disease, brain tumors, migraine, as well as, in long term sleep deprivation. VHs can also be presented as
the initial sign of the Epstein-Barr virus infection in infectious mononucleosis. Patients who suffer from CBS usually
possess insight into the unreality of their visual experiences, which are commonly pleasant but may sometimes cause dis-
tress. The hallucinations consist of well-defined, organized, and clear images over which the subject has little control. It
is believed that they represent release phenomena due to deafferentiation of the visual association areas of the cerebral
cortex, leading to a form of phantom vision. Cognitive defects, social isolation, and sensory deprivation have also been
implicated in the etiology of this condition. This study was conducted on 350 patients diagnosed with Age-Related Ma-
cular Degeneration (AMD) and shows incidence of CBS in 13% of patients with AMD. Furthermore, we have found
higher incidence of CBS in patients with massive loss of vision in peripheral visual field which is not age related.
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Introduction
Charles Bonnet Syndrome (CBS) is condition that
causes patients with visual loss to have complex visual
hallucinations (VHs), characterized as »Lilliputian« hal-
lucinations or micropsia. The condition was first de-
scribed by Charles Bonnet in 1760, and is most common
in the elderly but frequently goes unrecognized in clini-
cal practice, due to both lack of awareness among doctors
and patients unwillingness to admit the hallucinatory
experiences, mainly for reason of being labeled as men-
tally unstable1. Despite the fact that CBS is more com-
mon in elderly, usually due to the condition such as age –
related macular degeneration (AMD) or glaucoma, it
seems that appearance of CBS in children with visual
loss remains misdiagnosed mostly because of difficulties
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in verbal expression and description of VHs which are
the main diagnostic criteria for CBS2. Considering diffi-
culties in establishing the diagnosis of CBS in children
with visual impairment it is comprehensible why there
are just four cases of CBS described in the literature so
far2–4. However, it should be emphasized that variety of
pediatric conditions could be presented with symptoms
of VHs such as temporal or occipital epilepsy, migraine
and variety of inflammatory, vascular and expansive pro-
cesses in the brain. The term »Lilliputian hallucination«
was first introduced by John Todd, an English psychia-
trist (1914–1987) who also called it the Alice in Wonder-
land syndrome (AIWS) and is found in patients suffering
from severe migraine headache5. Furthermore, patients
with CBS who comprehend the unreality of their halluci-
nations may be distressed by the real fear of imminent
insanity. The hallucinations tend to be brief – lasting a
few seconds or minutes and re-appearing after hours,
days, months or even years. The VHs experiences in CBS
may be upsetting, but with time most patients recognize
them as hallucinations and usually learn to ignore
them6,7. In the recent studies on CBS patients a certain
pattern in the appearance of VHs was found. Patients
usually report apparitions that usually fall into a group
of categories including distorted faces and costumed fi-
gures7–11. The mechanism and neural basis responsible
for the VHs, experienced in CBS remains controversial,
with many hypotheses proposed9,12. The most commonly
accepted hypothesis is the deafferentiation theory. De-
afferentiation mechanism is defined as a loss of sensory
input from a portion of the body (periphery) to the brain
which is usually caused by interruption of the peripheral
sensory fibers12–14. This decreased peripheral sensory in-
put may stimulate increased intracerebral perception
which consequently triggers spontaneous neuronal dis-
charge (manifesting in the form of hallucinations) caused
by lack of visual-sensory input into the cortex. The brain
activity in the absence of visual input has been compared
with »phantom limb« or »phantom pain« syndromes13–15.
Another theory is the »release phenomenon« where mis-
sing peripheral input to primary visual areas causes a
disinhibition of visual association areas, contributing to
a release of visual hallucinations16. Over the years, sev-
eral neurobiological models have been proposed in order
to explain VHs in CBS. The most supported theory in-
volves deafferentiation, the phenomenon where reduced
afferent input creates, or releases, waves of discharges in
the visual areas of the brain. In other words, as the brain
is deprived of enough information from the eyes, it com-
pensates with abnormally increased activity and invokes
hallucinations from the random firing of nerve cells, a
phenomenon also seen after bilateral enucleation. Re-
cently, a neural network model approach has been used
to understand VHs formation8,17. The recurrent nature
of the VHs has been explained by adaptive character
within neural networks and loosing their sustainability
over the time. Studies conducted on CBS patents using
brain imaging such as functional MRI (fMRI) while they
were hallucinating showed that visual hallucinations
were related to increases in activity within specialized ar-
eas within visual cortex and that the location of the
increases defined the type of experience reported18. Gen-
erally speaking, color hallucinations are accompanied by
increased activity in the part of visual cortex specialized
for colors; face hallucinations by increased activity in cor-
tical parts specialized for faces; object hallucinations by
increased activity in cortical areas specialized for objects,
etc. The brain imaging studies such as functional mag-
netic resonance (fMRI) implied that each specialized vi-
sual area had its own associated hallucination and the
pathophysiology of the hallucinations involved a local-
ized increase in cerebral activity6,16,17. Moreover, numer-
ous neuroscientific studies on CBS showed exact location
within the brain regions which are related to the three
visual psycho-syndromes; ventral occipitotemporal cor-
tex activated by objects19,20 and extended scenes21, supe-
rior temporal region sensitive to eye movements and
gaze in face stimuli22,23 and intra-parietal region contain-
ing eye-centered reference frames.
Material and Methods
We have tested 350 patients previously diagnosed with
macular degeneration. The patients were divided into the
groups according to age and the percentage of central and
peripheral vision loss (macular area, peripheral visual
field). In order to make a diagnosis of Charles Bonnet syn-
drome and presence of VHs, patients were discretely ques-
tioned about images they may experience, quality of the
images (shape, color), and detailed description (if possible)
of persons or objects that are seen in VHs (after CBS con-
dition was carefully explained to them). Although an in-
sight into the unreal nature of the images and exclusion
of other mental disorders is required to make a diagnosis
of CBS, patients may not have full insight at the onset of
the symptoms. Patients may initially be confused about
what they are experiencing and may act on their halluci-
nations. They may have to regularly reassure themselves
that what they are seeing is not real, particularly if the
image fits into the real setting as lack of insight should
lead to consideration of other diagnoses.
Results
We have found positive symptoms of CBS with VHs
presented in 13% of patients with AMD. In the age group
of 40–55 years CBS was present in 5% of the cases while
in the elderly age group (56–80 years) CBS was present
in 17% of AMD cases. The difference in percentage of
CBS was specifically related to the stage of visual loss in
the central field (macular vision) and particularly to the
extent of damage within the peripheral visual field24–26.
The incidence of CBS was correlated with percentage of
visual loss in the central field and it was more common in
the group of patients with visual loss below 0.1. By de-
tailed examination and specific analysis of the visual
field defects we have found that incidence of CBS is
strongly correlated with percentage of visual loss and in-
creased deficits within peripheral visual field regardless
of the age group.
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Discussion
Charles Bonnet syndrome remains an under-recog-
nized and common disorder in persons with serious vi-
sual impairment. Speculation still exists concerning the
true pathophysiology of visual hallucinations in CBS,
and medical treatments are not well established6,10,12,17.
Other more serious etiologies of VHs must be ruled out
before arriving at a diagnosis of CBS, including meta-
bolic, toxic, neurological, and psychiatric disorders. Gen-
erally speaking, if the retina is damaged, the stream of
impulses to the brain is reduced but at the same time
other parts of the brain become hyperactive in order to
compensate visual loss at the periphery. When brain do
not receive as many pictures as it is used to, due to visual
loss in AMD or glaucoma, it builds its own artificial im-
ages within the areas that are normally responsible for
visual processing of faces, objects, landscapes and colors.
The type of visual hallucinations depends on which part
of the brain these increased impulses are located, but
why only proportion of patients with macular degenera-
tion experience visual hallucinations remains unknown,
as well as, why younger patients with macular degenera-
tion are less likely to have CBS than older ones. The
most acceptable hypothesis is that neurons within the
visual pathway from the retina to cortex become hy-
per-excitable, due to the loss of light receptors6,17,18. This
phenomenon has been observed directly in the brain. Re-
cently, neuroimaging technology has been used quite ex-
tensively in an attempt to understand the brain regions
and circuitry involved in the generation of hallucina-
tions12,16. Numerous structural and functional neuroima-
ging studies of patients with auditory and visual halluci-
nations as well as a small number of studies that have as-
sessed cognitive processes associated with hallucinations
in healthy volunteers suggests that in addition to second-
ary (and occasionally primary) sensory cortices, dysfunc-
tion in prefrontal premotor, cingulate, subcortical and
cerebellar regions also contribute to hallucinatory ex-
periences12,16–18. External visual stimuli are perceived in
the retina and are transmitted to the primary visual cor-
tex then to the secondary visual cortex and finally to the
visual association cortical area. In general, our percep-
tion of external visual stimuli normally has an inhibitory
effect on the endogenous activation of the visual cortex.
Visual loss due to certain conditions, of which eye pathol-
ogy (AMD, glaucoma, blindness) is the most commonly
postulated in CBS patients, produces a state of sensory
deprivation that releases the visual cortex from regula-
tion by external stimuli, resulting in visual hallucina-
tions (cortical release phenomenon). The results of previ-
ous neuroimaging studies suggest that the cortical relea-
se phenomenon hypothesis for the occurrence of visual
hallucinations in patients with CBS is highly proba-
ble12,17,18. In addition, the results indicate that not only
eye pathology, but also dysfunction in the primary and
secondary visual cortex could result in deprivation of ex-
ternal visual stimuli thereby producing random images.
Conclusion
Popular neuroscientific theory suggests that the brain
is attempting to compensate for a shortage of visual stim-
uli, especially when considering the fact that each hu-
man eye normally receives data at a rate of about 8.75
megabits per second, a bandwidth which is significantly
greater than most high-speed Internet connections. The
visual associative cortex is the most complex system in
the human brain, filled with neuronal pathways which
control processing of visual data before transferring it to
the conscious part of the brain12. When disease such as
AMD begins to twist that information, large network of
neurons are left standing »idle« (at rest) and then start-
ing to compensate the lack of visual information from the
periphery by random discharging and creating non-exis-
tent images10. In gradual-onset blindness such as in the
cases of AMD or glaucoma, it is possible that these com-
plex brain pathways attempt to fill in the new obscured
areas within the visual field. Since the damaged eyes are
sending reduced amounts of data from the periphery
with a greater frequency of errors, the visual cortex may
produce more and more bizarre guesses17. Our clinical
results are clearly showing that CBS appears in close re-
lation with degree of visual defects, particularly with
damage to the peripheral visual field frequently accom-
panied with optic nerve atrophy. We should also empha-
size that CBS is less correlated with loss in central vision.
Finally, we have concluded that CBS appears to be more
associated to the degree of deficit in peripheral vision
then to the patient’s age. The apparent neurobiologically
based clustering of VHs in CBS has implications which
extend beyond visual science. It suggests that syndro-
me’s links between specific pathological mental experi-
ences are not accidental or subjective details, but rather
a clue to the complex brain process and functional pa-
thology. Visual hallucinations in CBS provide a model for
generating and testing different neuroscientific hypothe-
ses of hallucinations in general12,17,18. Given the recent
prosperity in modern, neurobiologically based research
into the visual system over the last two decades, CBS
provides opportunity to study the detailed relationship
between psychopathology and the brain using modern
technology such as neuroimaging16. The challenge within
the field of modern psychiatry is to understand the com-
plex neurobiology of the visual system and thereby for-
mation of bizarre visual hallucinations in order to prop-
erly explain the associations between psychiatric symp-
toms and visual pathology in CBS.
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[TO POVEZUJE SINDROM »CHARLES BONNET« I MAKULARNU DEGENERACIJU?
S A @ E T A K
Sindrom »Charles Bonnet« (CBS) se nalazi kod pacijenata s o{te}enjem vida nastalim zbog makularne degeneracije
ili glaukoma, a karakterizira ga pojava kompleksnih vidnih halucinacija. Sindrom »Charles Bonnet« je prvi puta opisan
u literaturi 1760. godine od strane {vicarskog lije~nika Charles Bonnet-a. Pacijenti s CBS-om su mentalno zdrave osobe
sa zna~ajnim gubitkom vida i `ivopisnim vidnim halucinacijama (VHs) koje se stalno ponavljaju. Jedna od karakte-
ristika ovog tipa halucinacija su tzv. »Liliputanske halucinacije« tj. pojava mikropsije (vidne halucinacije u kojima su
slike likova i objekata iskrivljene i puno manjih dimenzija). Prevalencija sindroma »Charles Bonnet« u populaciji se
kre}e izme|u 10% i 40%, a nedavna australska studija je pokazala da je uobi~ajena prevalencija CBS-a oko 17,5%.
Smatra se da postoji visoka incidencija nedijagnosticiranog CBS-a zbog straha pacijenata od stigme mentalnih boles-
nika s obzirom na ~injenicu da se vidne halucinacije mogu na}i u nizu psihijatrijskih, ali i neurolo{kih poreme}aja kao
{to su zloporaba droga i alkohola (delirium tremens), sindroma »Alice iz zemlje ~udesa« (AIWS), psihoza, shizofrenije,
demencije, narkolepsije, epilepsije, Parkinsonove bolesti, mo`danih tumora, migrenske glavobolje te kod dugotrajnog
poreme}aja spavanja. Vidne halucinacije se mogu pojaviti i kao jedan od po~etnih simptoma kod infekcija kao {to je
infekcija virusom Epstein Barr (infekcijska mononukleoza). Pacijenti s CBS-om imaju uvid u svoje stanje tj. svjesni su
iskrivljenog realiteta tijekom do`ivljavanja vidnih halucinacija koje mogu biti sadr`ajno ugodna iskustva, ali i neugodna
{to kod pacijenata uzrokuje stanja jakog stresa. Smatra se da vidne halucinacije nastaju kao posljedica tzv. fenomena
otpu{tanja zbog deaferencijacije u vidnom asocijativnom korteksu velikog mozga, {to sve dovodi do tzv. fantomskog
vida. U etiologiji CBS-a inlau ulogu razni ~imbenici kao {to su kognitivni deficiti, socijalna izolacija i osjetilna depri-
vacija. Na{e istra`ivanje, koje je provedeno na 350 pacijenata s dijagnozom makularne degeneracije, pokazuje da je
incidencija CBS-a kod ove populacije 13%. Tako|er smo prona{li ve}u u~estalost pojave CBS-a kod pacijenata koji imaju
znatnija o{te}enja perifernog vida koje nije povezano s dobnom skupinom.
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